Purchase Order 36C25623P1148

Award Date 6/16/23
Potential Completion Date 12/26/23
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is a firm-fixed-price purchase order for the delivery of Novocure's Optune Tumor Treating Fields (TTFields) therapy transducers and related support services. The contract does not utilize any set-aside designations and is part of Novocure's 5-year Federal Supply...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, a component of the company's Tumor Treating Fields (TTFields) cancer therapy technology, over a 3-month period. This award is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune Transducers, which are part of Novocure's Optune system - an innovative cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is a firm...
This federal contract award to Novocure Inc., a foreign-owned manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price delivery order awarded under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This multiple-award...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune Plus transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers. The contract is structured as a firm fixed-price purchase order with a...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This contract does not utilize any set-aside designations and is being...
This federal contract award is for Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, to provide its Optune Transducer Plus products and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $49,748.73, is a delivery order (contract number 36F79723D0016) issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA. This multiple-award FSS contract, with a $28.85 million...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...

This federal contract award, valued at $49,748.73, is for the procurement of Novocure Transducer medical devices by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16), a civilian agency. The contract was awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using Tumor Treating Fields (TTFields) technology.

The contract does not utilize any set-aside designations and is a Firm Fixed Price Purchase Order with a performance period ending on December 26, 2023. Novocure delivers its proprietary Optune TTFields therapy products, including transducer arrays and associated support services, directly to VA medical centers nationwide, enabling the VA to offer this innovative cancer treatment option to veteran patients. This contract award is issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at a ceiling of $28.85 million, which provides a streamlined procurement vehicle for the VA to efficiently obtain Novocure's Optune cancer therapy technologies.

Generated 9/7/24, 12:03 PM